Cell Line Development Market Size, Share, Growth Analysis, By Product (Reagents & Media, Equipment), By Application (Bioproduction, Tissue Engineering), By Source (Mammalian Cell Line, Insects), By Region -Industry Forecast 2024-2031


Report ID: SQMIG35H2261 | Region: Global | Published Date: September, 2024
Pages: 203 |Tables: 0 |Figures: 0

Cell Line Development Market Insights

Global Cell line development Market was valued at USD 4.81 Billion in 2022 and is expected to rise from USD 5.28 Billion in 2023 to USD 11.16 Billion by 2031, at a CAGR of 9.8% during the forecast period (2024–2031).

Growing investments in the development of novel cell technologies and products coupled with advancements in cell technologies are projected to primarily drive cell line development market growth. Rising demand for personalized medicine and high investments in cell research around the world also create new opportunities for cell line development providers. Rapidly expanding demand for biosimilars and biologics to treat various diseases will also create new opportunities for cell line development companies. Rising emphasis on the development of new pharmaceuticals, therapeutics and vaccines to improve overall healthcare is also estimated to boost the demand for cell line development over the coming years. Rising use of gene editing technologies is projected to present highly lucrative opportunities for cell line development companies in the long run. However, high costs of development, ethical concerns, and roadblocks in scalability are projected to impede cell line development demand outlook across the study period and beyond.

Market Snapshot - 2024–2031

Global Market Size

USD 4.81 Billion

Largest Segment

Tissue engineering

Fastest Growth

Drug discovery

Growth Rate

9.8% CAGR

Global Cell Line Development Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cell Line Development Market Segmental Analysis

The cell line development market is segmented based on the type, source, product and service, application, and region. Based on the type, the cell line development market is segmented into recombinant cell lines, hybridomas, continuous cell lines, primary cell lines. Based on the Application, the market is segmented into bioproduction, drug discovery, toxicity testing, tissue engineering, others. Based on the product and service, the market is segmented into reagents & media, accessories and consumables, equipment, services. On the basis of source, the market is divided into mammalian cell line and non-mammalian cell line. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Analysis by Product and Service

Reagents and media are projected to account for a notable share of the global cell line development market. High use of reagents and media in almost all stages of cell line development and its crucial role in expanding the application scope of cell line development are all expected to help this segment maintain its high market share. Crucial role of reagents and media in drug development, toxicity testing, and other applications will also help this segment bring in major revenue going forward.

On the other hand, the demand for cell line development services is forecasted to rise at a robust pace across the forecast period and beyond. Surging emphasis on development of novel biosimilars and patent expiration of renowned biologics are projected to promote market growth via this segment. Moreover, increasing number of biotechnology companies outsourcing their operations and work is also estimated to favor the demand for cell line development services in the future.

Analysis by Application

Bioproduction is projected to account for a dominant share of cell line development demand over the coming years. High use of cell line development for the development of biologics, vaccines, biosmilars, and gene therapies is projected to help this segment maintain its high market share. Growing investments in the development of novel biopharmaceuticals and therapeutics around the world are projected to help bioproduction application maintain its dominant stance in the future.

Meanwhile, the use of cell line development for tissue engineering applications is projected to surge at an impressive pace across the study period. Rising demand for personalized medicine and growing demand for organ transplantation are projected to create new opportunities for cell line development companies via this segment. High investments in the research and development of novel tissue engineering technologies will also create opportunities for cell line development providers in the long run.

Global Cell Line Development Market By Product & Service

To get detailed analysis on other segments, Request For Free Sample Report

Cell Line Development Market Regional Insights

North America is estimated to lead the demand for cell line development in the world owing to high investments in medical R&D and the presence of a developed healthcare infrastructure. Presence of key biotechnology companies and supportive government initiatives to advanced medical research are also expected to create new opportunities for cell line development companies. Growing awareness regarding benefits of novel biologics and increased adoption of the same will also help this region’s dominance. The United States is projected to be the top market for cell line development companies in this region.

Asia Pacific region is slated to emerge as the most opportune market for cell line development companies on a global level. Presence of key contract research organizations, low costs of research, supportive regulatory frameworks, and increasing healthcare expenditure are key factors that are forecasted to create new opportunities for cell line development companies in this region. Rapidly increasing investments in healthcare infrastructure development and growing awareness regarding healthcare will also bolster cell line development market growth in the future. China, Japan, and India are slated to be the most lucrative markets in this region.

Global Cell Line Development Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cell Line Development Market Dynamics

Drivers

High Investments in Cell Research

  • Healthcare researchers around the world are focusing on unlocking the full potential of cells and this has resulted in significant investments in cell research. Cell line development plays a crucial role in cell research thereby driving market growth potential as well.

Demand for Personalized Medicine

  • Personalized medicine is gaining massive traction around the world and the demand for the same to cure multiple chronic diseases is also increasing. Development of personalized medicine can be expedited by the use of advanced cell lines thereby driving market development in the future.

Restraints

High Costs of Development

  • Cell lines are extremely complex and intricate to develop, which makes them expensive and adds up to the overall costs of development. Moreover, the requirement of advanced technologies and consistency in cell lines further adds to the costs of development and slows down cell line development demand.

Ethical Concerns and Regulatory Challenges

  • Cell line development faces ethical challenges as it involves cell engineering of cells sourced from humans or animals. Rising focus on reducing animal cruelty and imposition of stringent regulations for cell research are projected to impede cell line development market development going forward.

Request Free Customization of this report to help us to meet your business objectives.

Cell Line Development Market Competitive Landscape

Creating cell lines for specific applications will help companies maximize their business scope and also set them apart from the competition. Developing novel cell line development products and services will also help boost market growth over the coming years. Cell line development companies can take advantage of supportive government initiatives and funding to maximize their business scope in the long run.

Top Player’s Company Profiles

  • Creative BioLabs
  • WuXi AppTec Co. Ltd.
  • American Type Culture Collection Inc.
  • Berkely Lights
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • Danaher
  • Corning Incorporated
  • Merck KGaA
  • Selexis SA
  • Abzena plc.
  • Sartorius AG
  • General Electric Company

Recent Developments

  • New cell line development platforms were launched in May 2024 by Abzena, a leading biotechnology company based in the United States. The AbZelect platforms were aimed at advancing cell line development processes around the world.
  • New cell lines were launched by Lonza back in November 2023 for the development of therapeutic antibodies. The launch of GS Effex® cell line was aimed at addressing the increasing sophistication and complexity of therapeutic antibodies.
  • A new microfluidics-based solution was launched by Sphere Fluidics in June 2024 to advance cell line development. Cyto-Cellect®PLUS is projected to streamline cell line development workflows in conjunction with Sphere Fluidics’ Cyto-Mine® platform.

Cell Line Development Key Market Trends

  • 3D Cell Culture: Cell line development companies can ride the wave of rising demand for 3D cell culture and organoid development to maximize their business potential in the future. Providing cell line development specifically aimed at advancing 3D cell culture and organoid development could be the key to maximizing business growth in the long run.
  • Use of Artificial Intelligence: Cell line development companies can leverage the use of advanced technologies such as artificial intelligence and machine learning to automate different tasks. Use of these advanced technologies can also help improve efficiency of cell line development operations in the future.

Cell Line Development Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, growing investments in cell research and rising demand for personalized medicine are projected to bolster the demand for cell line development over the coming years. On the contrary, high costs of development and stringent regulations are estimated to slow down market growth potential across the study period. North America is forecasted to spearhead the global demand for cell line development owing to presence of key biotechnology companies and high investments in cell research. Cell line development market players can explore the use of advanced technologies to maximize their business potential in the future.

Report Metric Details
Market size value in 2022 USD 4.81 Billion
Market size value in 2031 USD 11.16 Billion
Growth Rate 9.8%
Base year 2023
Forecast period 2024–2031
Forecast Unit (Value) USD Billion
Segments covered
  • Application
    • Bioproduction, Drug discovery, Toxicity testing, Tissue engineering, Others
  • Source
    • Mammalian cell line, Non-mammalian cell line
  • Type
    • Recombinant cell lines, Hybridomas, Continuous cell lines, Primary cell lines
  • Product and Service
    • Reagents & Media, Accessories and Consumables, Equipment, Services
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Creative BioLabs
  • WuXi AppTec Co. Ltd.
  • American Type Culture Collection Inc.
  • Berkely Lights
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • Danaher
  • Corning Incorporated
  • Merck KGaA
  • Selexis SA
  • Abzena plc.
  • Sartorius AG
  • General Electric Company
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cell Line Development Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cell Line Development Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cell Line Development Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Line Development Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Line Development Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cell Line Development Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell line development Market was valued at USD 4.81 Billion in 2022 and is expected to rise from USD 5.28 Billion in 2023 to USD 11.16 Billion by 2031, at a CAGR of 9.8% during the forecast period (2024–2031).

Creating cell lines for specific applications will help companies maximize their business scope and also set them apart from the competition. Developing novel cell line development products and services will also help boost market growth over the coming years. Cell line development companies can take advantage of supportive government initiatives and funding to maximize their business scope in the long run. 'Creative BioLabs', 'WuXi AppTec Co. Ltd.', 'American Type Culture Collection Inc.', 'Berkely Lights', 'Sigma-Aldrich Corporation', 'Thermo Fisher Scientific Inc.', 'Lonza Group Ltd.', 'Danaher', 'Corning Incorporated', 'Merck KGaA', 'Selexis SA', 'Abzena plc.', 'Sartorius AG', 'General Electric Company'

Healthcare researchers around the world are focusing on unlocking the full potential of cells and this has resulted in significant investments in cell research. Cell line development plays a crucial role in cell research thereby driving market growth potential as well.

3D Cell Culture: Cell line development companies can ride the wave of rising demand for 3D cell culture and organoid development to maximize their business potential in the future. Providing cell line development specifically aimed at advancing 3D cell culture and organoid development could be the key to maximizing business growth in the long run.

North America is estimated to lead the demand for cell line development in the world owing to high investments in medical R&D and the presence of a developed healthcare infrastructure. Presence of key biotechnology companies and supportive government initiatives to advanced medical research are also expected to create new opportunities for cell line development companies. Growing awareness regarding benefits of novel biologics and increased adoption of the same will also help this region’s dominance. The United States is projected to be the top market for cell line development companies in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2261

$5,300
BUY NOW GET FREE SAMPLE